Advertisement
Home Latest Headlines

Latest Headlines

HLA-E Binding Peptide May Serve as a Viable Treatment Candidate for High-Risk Multiple Myeloma...

A study found that a high expression of the coding gene human leukocyte antigen-E (HLA-E) is associated with advanced disease state of multiple myeloma...

Access to MM Clinical Trial Sites Varies by County

A new study reports on county-level socioeconomic disparities in the distribution of multiple myeloma (MM) clinical trial sites in North Carolina. “linical trial participants are...

Racial Disparities in Use of HCT for Multiple Myeloma

A study did not observe racial disparities in the use of autologous hematopoietic cell transplantation (HCT) consolidative therapy for multiple myeloma (MM) for Black...
Doctor explaining test results to patient

Second Primary Malignancies in MM by Race

Researchers for a recent study evaluated the prevalence and characteristics of second primary malignancies (SPMs) in Black and white patients with multiple myeloma (MM)...

Despite Benefits, Hematologists May Hesitate to Promote Exercise to Patients with Multiple Myeloma

Although physical activity and exercise programs have shown benefit for patients with multiple myeloma (MM), clinical hematologists may under-recommend these regimens to their patients with...

Pain-Reported Pain Severity Is Associated with Poor Outcomes in Multiple Myeloma

In patients with multiple myeloma (MM), higher patient-rated pain severity was found to be significantly associated with poorer health-related quality of life (HRQOL). This...

Multiple Myeloma Cases Have More Than Doubled Since 1990

Incidence of multiple myeloma (MM) has more than doubled globally since 1990, according to an analysis published in BMC Cancer. In order to evaluate the global...

Comparable QOL Benefit for Triplet vs. Quadruplet Regimen in Transplant-Ineligible MM

Treatment with a regimen of bortezomib, melphalan, and prednisone (VMP) with or without daratumumab (D-VMP) led to similar improvements in patient-reported quality of life...

Stem Cell Transplant for MM Is Less Common in Older Patients with Comorbidities

Real-world data showed that upfront autologous hematopoietic stem cell transplantation (AHCT) for treatment of multiple myeloma (MM) was less frequently used in older patients...

Infection Most Common Cause of ICU Admission After Stem Cell Transplant

Infection is a major driver of intensive care unit (ICU) admissions after hematopoietic cell transplantation (HCT), according to a study published in Hematology. Researchers from the...
Advertisement
Advertisement